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I~  Relationship between growth, nutritional status and pulmonary 
function in children and adolescents with Cystic Fibrosis 
E. Hatziagorou 1 , R Anagnostopoulou 1 , F. Kirvasilis 1 , R Savopoulou 1 , J. Kioumis 2, 
J. Tsanakas 1 . 13rd Paediatric Dept, Paediatric Pulmonology Unit, Hippokration 
Hospital, 2Dept of Pulmonology, Papanikolaou Hospital, Thessaloniki, Greece 
Background; Nutritional status and lung function are associated with survival in 
Cystic Fibrosis (CF). 
Aim; To determine the relationship among growth, nutritional status and pulmonary 
function in children and adolescents with CE 
Methods; A cohort of 48 children aged 6 to 10 was followed every 4 months over 
a 13-year period at Thessaloniki CF center. Weight-for age, (WFA), height-for- 
age (HFA), percent ideal body weight (%IBW) and pulmonary function test (PFT) 
results were recorded. 
Results; The prevalence of abnormal weight for height (<90%) increased with 
age from 19% in children aged <7 years to 40% in adults with CE Patients with 
malnutrition had significantly lower mean values of Forced Vital Capacity (FVC) 
and Forced Expiratory Volume in one second (FEV1) (p < 0.05). Longitudinal 
follow-up showed that malnourished patients had significantly worse lung function 
than their normally nourished counterparts and a greater yearly loss of FEV1. 
Conclusions; Our data emphasize the close relationship between nutrition, lung 
function and clinical course in CE 
5. Immunology pulmonology 
I~  Comparing the clinical evolution of Cystic Fibrosis patients with 
meconium ileus and with nonmeconium ileus diagnosed under 
two months 
S. Pekcan, N. Cobanoglu, E. Yalcin, D. Dogru, U. Ozcelik, N. Kiper. Hacettepe 
University Pediatric Chest Diseases Unit, Ankara, Turkey 
Meconium ileus (MI) is the earliest symptom of cystic fibrosis (CF) and is the 
presenting feature in 6 20% of causes of cystic fibrosis. 
Aim; To show the difference between the patients with CF with MI and with 
nonmeconium ileus (nMI) for hospitalization for pulmonary complications and 
pseudo-Bartter syndrome (PB), colonization with Pseudomonas aeroginosa (Pa) 
and Staphylococcus' aureus (Sa), the status of growth with Body Mass Index (BMI). 
Method: We have performed a retrospective study for the previous data of 
195 patients with CF who were treated in Hacettepe University Hospital between 
January 1987-December 2005. We have identified 14 cases of classical CF with MI 
by using radiological, sweat and genotype testing and compared them with 23 CF 
patients with nMI, who were diagnosed under two months old, for hospitalization 
for pulmonary complications and for PB, for colonization with Pa and Sa, for the 
status of growth. 
Results: Of 14 CF patients with MI one patient had Pa colonization, and of 23 
CF patients with nMI two patients had Pa colonization and two patients had Sa 
colonization (p > 0.837). Eight CF patients with MI and 11 CF patients with nMI 
have been hospitalized with pulmonary infection (p > 0.916). Seven CF patients 
with MI and 13 CF patients with nMI have been hospitalized with PB (p > 0.102). 
We also could not find a difference between two groups for the last BMI results 
(p > 0.975). 
Conclusion; We did not find a significant difference between two groups for the 
respiratory status, BMI, hospitalization for PB, and colonization with Pa and Sa. 
I •  Lung transplantation in CF patients on mechanical ventilation 
and ECMO 
L. Mared, L. Eriksson, U. Dennersten, L. Algotsson, B. Koul. Heart and Lung 
Cente~ Lurid University Hospital, Lurid, Sweden 
Background: It is not recommended to perform lung transplantation (Tx) on CF 
patients while on ventilator. We have successfully transplanted 3 CF patients on 
ventilator and extra-corporeal membrane oxygenation (ECMO). Mean follow up 
835 days, all alive. 
Description: Our patients were between 24 and 44 yo, 1 E One patient was on 
waiting list (WL) and two were transplanted under acute circumstances. All were 
colonized with Pseudomonas eruginosa (PA) and one also C. acidovorans. 
The female patient had a pneumothorax with accompanying subcutaneous em- 
physema. Last measured FEV1 was 31% of predicted. She was treated with 
high frequency oscillating ventilation (HFO) combined with controlled mechanical 
ventilation (MV) for 22 days and 10 days on ECMO before Tx. 
One patient was slowly deteriorating and on WL for 49 days when hospitalised. 
FEV1 21% of predicted. On non-invasive ventilation for 30 days. On ECMO with 
PCO 2 17kPa the day before Tx. 
Our last patient was rapidly deteriorating with pneumonia nd large hilar nodes. 
Accepted for Tx after 21 days in hospital. On MV with PCO 2 15 kPa and pH 7.25. 
Tx after 10 days on MV and 6 days on ECMO. 
All patients were treated with airway clearing therapy (ACT) sessions 2 4 times per 
day combined with inhalations. Bronchoscopy for bronchial clearing was performed 
as needed, usually once daily. The amount of evacuated sputum varied between 
100mL and 500mL per session. ACT and bronchoscopy were often done at the 
same time. The patients were put on ECMO when we could not clear hypercapnia 
and reach acceptable oxygenation i spite of the treatment. 
Conclusion: Tx on CF patients on MV and ECMO is possible with good results. 
ACT has to be performed regularly with competent physiotherapists. Cooperation 
between the involved specialties i important. 
1• Adults with Cystic Fibrosis: a single centre experience over five 
years 
M. Hofer 1 , C. Schmid 2, B. Miillhaupt 3, D. Holzmann 4, A. Boehler 1. 1Department 
of Pneumology, 2Department ofEndocrinology, 3Department ofGastroenterology, 
4ENT department, University Hospital, Zurich, Switzerland 
Aim; To better characterise the patients of our adult CF program. 
Method; Retrospective analysis of patient charts over the last 5 years. 
Result; The actual number of patients in our program is 24 (11 women and 13 men). 
Median age is 25.8 y (range 18.8 50.6). Most patients have moderate to severe 
obstructive lung disease with a median FEV1 of 1.68 litre (0.67 4.13), 54.5% 
predicted (19 100%). Actual body mass index is median 20.8 kg/m 2 (17.0 28.2). 
There was no significant change in BMI over the last year. Fourteen (58.3%) 
have chronic infection with P aeruginosa (PA), 6 (25%) have no infection with 
PA, and 4 (16.7%) grow PA intermittently. No patient had an infection with 
B. cepacia. Three (12.5%) patients had an infection with an atypical mycobacterium. 
Five (20.8%) patients have CF-related diabetes mellitus and 2 have significant 
osteoporosis. Intermittent haemoptoe was present in 6 (25%), pneumothorax in 2, 
and classic allergic bronchopulmonary spergillosis n 2. Since the start of the adult 
CF program, no patient died; one had successful lung transplantation. However, lung 
function decreased significantly over the last year: loss of FEV1 (p < 0.01): median 
125ml (range 700 to +170ml). This was independent of gender, the presence 
of PA-infection and diabetes. Fourteen (58.3%) of the 24 patients had at least one 
significant infect exacerbation. In our population, according to the Liou-score (Am 
J Epidemiol, 2001), estimated 5-survival is high: median 91% (33 100%). 
Conclusion; In our adult CF program only 60% of the patients are chronically 
infected with PA. Most of the patients have a moderate to severe impairment 
of pulmonary function with at least one significant infect exacerbation per year. 
Nevertheless, estimated 5-year survival according to the Liou-score is high. 
